Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2023-08-09

FDA Approved: TALVEY — Original Application (Janssen Biotech, Inc.)

View source ↗

Summary

FDA approves TALVEY (talquetamab) from Janssen Biotech as an original Biologics License Application for adults with multiple myeloma who have received at least …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • TALVEY (talquetamab)

Snippet

ORIG AP for TALVEY (TALQUETAMAB)